Loading...
XHKG3332
Market cap79mUSD
Dec 23, Last price  
0.60HKD
1D
3.45%
Jan 2017
-64.07%
IPO
-77.78%
Name

Nanjing Sinolife United Co Ltd

Chart & Performance

D1W1MN
XHKG:3332 chart
P/E
11.06
P/S
1.03
EPS
0.05
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
4.47%
Revenues
564m
+105.19%
150,372,000194,736,000252,449,000397,064,000466,241,000472,490,000453,199,000322,613,000296,525,000252,325,000274,851,000563,959,000
Net income
53m
P
57,237,00070,786,000107,873,000136,233,00087,232,0004,209,000-112,837,000-194,658,000-49,605,000-31,707,000-14,246,00052,602,000
CFO
47m
+495.19%
57,923,00082,076,00087,649,000104,658,00077,712,000-108,740,00030,577,000-68,136,00016,408,000421,0007,915,00047,109,000
Dividend
Jul 06, 20170.0457 HKD/sh
Earnings
Jun 06, 2025

Profile

Nanjing Sinolife United Company Limited, an investment holding company, engages in the manufacture, processing, and sale of nutritional supplements in the People's Republic of China, Australia, New Zealand, Vietnam, and internationally. The company is also manufactures and sale of cosmetics and skin care products; and trading, retail, and testing of packaged health food products. It sells its products under the Good Health, Zhongsheng, Hejian, and Cobayer series through a network of retail stores. The company also sells its products through distributors, TV shopping, and e-commerce platforms; and chain pharmacies, health goods supermarkets, and tourist souvenir shops. Nanjing Sinolife United Company Limited was incorporated in 1999 and is headquartered in Nanjing, China.
URL
http://www.zs-united.com/
IPO date
Jan 15, 2014
Employees
319
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
563,959
105.19%
274,851
8.93%
252,325
-14.91%
Cost of revenue
507,353
288,219
291,015
Unusual Expense (Income)
NOPBT
56,606
(13,368)
(38,690)
NOPBT Margin
10.04%
Operating Taxes
5,491
3,746
(1,392)
Tax Rate
9.70%
NOPAT
51,115
(17,114)
(37,298)
Net income
52,602
-469.24%
(14,246)
-55.07%
(31,707)
-36.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,143
4,368
4,285
Long-term debt
66,183
67,138
13,455
Deferred revenue
Other long-term liabilities
14,279
774
740
Net debt
(52,468)
(1,885)
(54,317)
Cash flow
Cash from operating activities
47,109
7,915
421
CAPEX
(2,345)
(3,864)
(10,097)
Cash from investing activities
449
(3,467)
1,522
Cash from financing activities
(4,498)
(4,078)
(4,448)
FCF
36,595
(32,787)
(10,003)
Balance
Cash
122,794
73,391
72,057
Long term investments
Excess cash
94,596
59,648
59,441
Stockholders' equity
(112,665)
(276,325)
(262,825)
Invested Capital
540,176
635,243
600,901
ROIC
8.70%
ROCE
13.24%
EV
Common stock shares outstanding
946,298
946,298
946,298
Price
0.23
94.92%
0.12
-24.84%
0.16
12.14%
Market cap
217,649
94.92%
111,663
-24.84%
148,569
12.14%
EV
221,083
109,778
101,308
EBITDA
70,317
1,541
(19,765)
EV/EBITDA
3.14
71.24
Interest
3,280
472
685
Interest/NOPBT
5.79%